Company No:
Contents
| DIRECTOR | I Seragnoli |
| REGISTERED OFFICE | C/O S&W Partners Llp Onslow House |
| Onslow Street | |
| Guildford | |
| GU1 4TL | |
| United Kingdom |
| COMPANY NUMBER | 13881660 (England and Wales) |
| ACCOUNTANT | S&W Partners LLP |
| 103 Colmore Row | |
| Birmingham | |
| B3 3AG |
| Note | 2026 | 2025 | ||
| £ | £ | |||
| Fixed assets | ||||
| Investments | 3 |
|
|
|
| 1,195,986 | 1,164,112 | |||
| Current assets | ||||
| Cash at bank and in hand |
|
|
||
| 13,440 | 16,498 | |||
| Creditors: amounts falling due within one year | 4 | (
|
(
|
|
| Net current liabilities | (1,165,465) | (1,156,547) | ||
| Total assets less current liabilities | 30,521 | 7,565 | ||
| Net assets |
|
|
||
| Reserves | ||||
| Profit and loss account |
|
|
||
| Total reserves |
|
|
Director's responsibilities:
The financial statements of CLG Legacy Limited (registered number:
|
I Seragnoli
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.
CLG Legacy Limited (the Company) is a private company, limited by guarantee, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is C/O S&W Partners Llp Onslow House, Onslow Street, Guildford, GU1 4TL, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with ‘The Financial Reporting Standard applicable in the UK and the Republic of Ireland’ issued by the Financial Reporting Council, including Section 1A of Financial Reporting Standard 102 (FRS102), and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The functional currency of CLG Legacy Limited is considered to be pounds sterling because that is the currency of the primary economic environment in which the Company operates.
These financial statements are separate financial statements.
The financial statements have been prepared on a going concern basis.
The director has made an assessment in preparing these financial statements as to whether the Company is a going concern and have concluded that there are no material uncertainties that may cast significant doubt on the Company's ability to continue as a going concern for a period of at least 12 months from the date of approval of these financial statements.
Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise on monetary items.
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.
Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.
Investments in unlisted company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.
Trade and other debtors and creditors are classified as basic financial instruments and measured on initial recognition at transaction price. Debtors and creditors are subsequently measured at amortised cost using the effective interest rate method. A provision is established when there is objective evidence that the Company will not be able to collect all amounts due.
Cash and cash equivalents are classified as basic financial instruments and comprise cash in hand and at bank, short term bank deposits with an original maturity of three months or less and bank overdrafts which are an integral part of the Company’s cash management.
Financial liabilities and equity instruments issued by the Company are classified in accordance with the substance of the contractual arrangements entered into and the definitions of a financial liability and an equity instrument. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of
its liabilities. Equity instruments issued by the Company are recorded at the proceeds received, net of direct issue costs.
| 2026 | 2025 | ||
| Number | Number | ||
| Monthly average number of persons employed by the Company during the year, including the director |
|
|
Investments in subsidiaries
| 2026 | |
| £ | |
| Cost | |
| At 01 February 2025 |
|
| At 31 January 2026 |
|
| Carrying value at 31 January 2026 |
|
| Carrying value at 31 January 2025 |
|
On 2 May 2024, the Company acquired 100% of the issued quota capital of IST S.r.l., a private limited liability company incorporated and registered in Italy, for a total cash consideration of £142,000. IST S.r.l. is based in Milan, Italy.
The acquisition was settled entirely in cash, and no contingent consideration was agreed as part of the transaction.
The investment has been recognised in the Company's financial statements at cost, in accordance with the applicable accounting standards for individual financial statements.
The purchase consideration of £142,000 reflected the net assets (equity) of IST S.r.l. at the acquisition date. Accordingly, no acquisition premium arose on the transaction and, therefore, no amount would be attributable to goodwill or other acquisition-related intangible assets as a result of the acquisition.
| Listed investments | Total | ||
| £ | £ | ||
| Cost or valuation before impairment | |||
| At 01 February 2025 |
|
|
|
| Additions |
|
|
|
| Disposals | (
|
(
|
|
| Movement in fair value |
|
|
|
| At 31 January 2026 |
|
|
|
| Carrying value at 31 January 2026 |
|
|
|
| Carrying value at 31 January 2025 |
|
|
| 2026 | 2025 | ||
| £ | £ | ||
| Amounts owed to director |
|
|
|
| Accruals |
|
|
|
| Taxation and social security |
|
|
|
|
|
|
The members of the CLG Legacy Limited have undertaken to contribute a sum not exceeding £1 each to meet the liabilities of the Company if it should be wound up.
At the year end, there is an amount of £1,159,978 (2025 - £1,159,978) owed to the directors by the Company. These loans are unsecured, interest free and repayable on demand